The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 1,601–1,800 of 3,517
Physical symptoms of depression: unmet needs.
Greden, J. F. (2003) · PubMed · Cited by 138
Treatment of obesity: an update on anti‐obesity medications
Halpern, A., & Mancini, M. C. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00083.x · Cited by 138
Manahan-Vaughan, D., & Braunewell, K.-H. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi047 · Cited by 138
Ballesteros, J., & Callado, L. F. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00404-4 · Cited by 138
Zhang, H., & Sulzer, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10585.2003 · Cited by 138
Chronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines
Lauterborn, J. C., Truong, G. S., Baudry, M., Bi, X., LYNCH, G. S., & Gall, C. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053694 · Cited by 138
Gallopin, T., Luppi, P., Rambert, F. A., Frydman, A. M., & Fort, P. (2004) · SLEEP · doi:10.1093/sleep/27.1.19 · Cited by 138
Prickaerts, J., Şık, A., van der Staay, F. J., de Vente, J., & Blokland, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1967-7 · Cited by 138
The economic burden of depression with painful symptoms.
Greenberg, P. E., Leong, S. A., Birnbaum, H. G., & Robinson, R. L. (2003) · PubMed · Cited by 137
Pharmacogenomics and ???Individualized Drug Therapy???
Nebert, D. W., Jorge-Nebert, L. F., & Vesell, E. S. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303060-00002 · Cited by 137
Haddjeri, N., Blier, P., & de Montigny, C. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00003 · Cited by 137
NEUROBIOLOGY OF l-DOPAergic SYSTEMS
Misu, Y., Goshima, Y., Ueda, H., & OKAMURA, H. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00025-1 · Cited by 137
Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation
Sørensen, G., Lindberg, C., Wörtwein, G., Bolwig, T. G., & Woldbye, D. P. D. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20200 · Cited by 137
Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinsonʼs disease
Jenner, P. G. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200312001-00002 · Cited by 137
Lucas, G., Compan, V., Charnay, Y., Neve, R. L., Nestler, E. J., Bockaert, J., Barrot, M., & Debonnel, G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.023 · Cited by 137
Strong links are important, but weak links stabilize them
Csermely, P. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.05.004 · Cited by 137
THE PINEAL GLAND AND MELATONIN: Molecular and Pharmacologic Regulation
Borjigin, J., Li, X., & Snyder, S. H. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.53 · Cited by 137
Residual symptoms in depression
Fava, G. A., Fabbri, S., & Sonino, N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00226-9 · Cited by 137
PAYKEL, E. S., SCOTT, J., CORNWALL, P. L., ABBOTT, R., CRANE, C., POPE, M., & JOHNSON, A. L. (2005) · Psychological Medicine · doi:10.1017/s003329170400282x · Cited by 136
Magnetic Seizure Therapy Improves Mood in Refractory Major Depression
Kosel, M., Frick, C., Lisanby, S. H., Fisch, H.-U., & Schlaepfer, T. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300293 · Cited by 136
Czeh, B., Simon, M., van der Hart, M. G., Schmelting, B., Hesselink, M. B., & Fuchs, E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300581 · Cited by 136
Popoli, M., Brunello, N., Pérez, J., & Racagni, G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740021.x · Cited by 136
Ren‐Patterson, R. F., Cochran, L. W., Holmes, A., Sherrill, S., Huang, S., Tolliver, T. J., Lesch, K., Lu, B., & Murphy, D. L. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20410 · Cited by 136
Jackson, H. C., Needham, A. M., Hutchins, L. J., Mazurkiewicz, S. E., & Heal, D. J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701312 · Cited by 136
Pałucha-Poniewiera, A., Tatarczynska, E., Brański, P., Szewczyk, B., Wierońska, J. M., Kłak, K., Chojnacka-Wójcik, E., Nowak, G., & Pilc, A. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.006 · Cited by 136
Nonsynaptic communication in the central nervous system
Vizi, E. S., Kiss, J., & Lendvai, B. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.016 · Cited by 136
Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years
Rey, J. M., Martin, A., & Krabman, P. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000135623.12843.60 · Cited by 136
Uberti, M. A., Hague, C., Oller, H., Minneman, K. P., & Hall, R. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079541 · Cited by 136
Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety
Martin, J. R., Ballard, T. M., & Higgins, G. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00713-4 · Cited by 136
Klimke, A., Larisch, R., Janz, A., Vosberg, H., Müller-Gärtner, H. W., & Gaebel, W. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 136
A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus
Lü, X., Barr, A. M., Kinney, J. W., Sanna, P. P., Conti, B., Behrens, M. M., & Bartfai, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408891102 · Cited by 136
AMPA receptor modulators as cognitive enhancers
LYNCH, G. S. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.09.009 · Cited by 136
Castanon, N., Bluthé, R.-M., & Dantzer, R. (2001) · Psychopharmacology · doi:10.1007/s002130000595 · Cited by 136
Lang, U. E., Jockers-Scherübl, M. C., & Hellweg, R. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0100-0 · Cited by 136
Pickard, G. E., Weber, E. T., Scott, P. A., Riberdy, A., & Rea, M. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08208.1996 · Cited by 136
Zhang, H., & O’Donnell, J. M. (2000) · Psychopharmacology · doi:10.1007/s002130000414 · Cited by 136
Mirtazapine Augmentation in the Treatment of Refractory Depression
Carpenter, L. L., Jocic, Z., Hall, J. M., Rasmussen, S. A., & Price, L. H. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0110 · Cited by 136
Aslan, S., Isik, E., & Cosar, B. (2002) · Sleep · doi:10.1093/sleep/25.6.666 · Cited by 135
Mitchell, S. J., & Silver, R. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08651.2000 · Cited by 135
Antiglucocorticoid therapies in major depression: A review
Murphy, B. E. P. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00021-8 · Cited by 135
Knable, M. B., Torrey, Ε. F., Webster, M. J., & Bartko, J. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00521-4 · Cited by 135
Martínez-Turrillas, R., Frechilla, D., & Río, J. D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00299-x · Cited by 135
Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats
Laszy, J., Laszlovszky, I., & Gyertyán, I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2096-z · Cited by 135
Bhushan, R. G., Sharma, S. K., Xie, Z., Daniels, D. J., & Portoghese, P. S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0342358 · Cited by 135
Combining Bupropion SR With Venlafaxine, Paroxetine, or Fluoxetine
Kennedy, S. H., McCann, S., Masellis, M., McIntyre, R. S., Raskin, J., McKay, G., & Baker, G. B. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0302 · Cited by 135
Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits
Mombereau, C., Kaupmann, K., Gassmann, M., Bettler, B., van der Putten, H., & Cryan, J. F. (2005) · Neuroreport · doi:10.1097/00001756-200502280-00021 · Cited by 135
Ashton, A. K., Hamer, R. M., & Rosen, R. C. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403922 · Cited by 135
N-methyl-d-aspartate-induced excitation and sensitization of normal and inflamed nociceptors
Du, J., Zhou, S., Coggeshall, R. E., & Carlton, S. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00009-5 · Cited by 135
Delgado, P. L., Brannan, S. K., Mallinckrodt, C. H., Trân, P. V., McNamara, R. K., Wang, F., Watkin, J. G., & Detke, M. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0603 · Cited by 135
Melatonin receptor subtype expression in human cerebellum
Al‐Ghoul, W. M., Herman, M. D., & Dubocovich, M. L. (1998) · Neuroreport · doi:10.1097/00001756-199812210-00011 · Cited by 135
Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S. J., Rizzo, S. J. S., Dawson, L. A., Marquis, K. L., Jones, D., Piesla, M. J., Andree, T. H., Nawoschik, S. P., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086363 · Cited by 135
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott-Hazard, S., Morgan, D., DeLeon-Jones, F. A., Overstreet, D. H., & Janowsky, D. S. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 135
Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory
Yasuno, F., Suhara, T., Nakayama, T., Ichimiya, T., Okubo, Y., Takano, A., Ando, T., Inoue, M., Maeda, J., & Suzuki, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.334 · Cited by 135
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
Watts, V. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.1 · Cited by 135
Corticosteroids: Sculptors of the Hippocampal Formation
Sousa, N., & Almeida, O. F. X. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.1.59 · Cited by 135
Södersten, P., Henning, M., Melin, P., & Ludin, S. M. (1983) · Nature · doi:10.1038/301608a0 · Cited by 134
PKC-interacting proteins: from function to pharmacology
Poole, A. W., Pula, G., Hers, I., Crosby, D. A., & Jones, M. L. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.08.006 · Cited by 134
Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression
Zanardi, R., Franchini, L., Serretti, A., Pérez, J., & Smeraldi, E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0107 · Cited by 134
Ben‐Shachar, D., Gazawi, H., Riboyad-Levin, J., & Klein, E. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01119-6 · Cited by 134
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor
Puech, A. J., Montgomery, S., Prost, J. F., Solles, A., & Briley, M. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199703000-00005 · Cited by 134
A Comparison of Melatonin Secretion in Depressed Patients and Normal Subjects
Thompson, C., Franey, C. S., Arendt, J., & Checkley, S. A. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.152.2.260 · Cited by 134
Evidence of cost-effective treatments for depression: a systematic review
Barrett, B. M., Byford, S., & Knapp, M. R. J. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.10.003 · Cited by 134
Depression, sleep, and antidepressants.
Thase, M. E. (1998) · PubMed · Cited by 134
Dual Monoamine Modulation for Improved Treatment of Major Depressive Disorder
Trân, P. V., Bymaster, F. P., McNamara, R. K., & Potter, W. Z. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00011 · Cited by 134
Linden, M., Lecrubier, Y., Bellantuono, C., Benkert, O., Kisely, S., & Simon, G. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00007 · Cited by 133
Kannari, K., Yamato, H., Shen, H., Tomiyama, M., Suda, T., & Matsunaga, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00184.x · Cited by 133
Murphy, D. L., Uhl, G. R., Holmes, A., Ren‐Patterson, R. F., Hall, F. S., Sora, I., Detera‐Wadleigh, S. D., & Lesch, K. (2003) · Genes Brain & Behavior · doi:10.1046/j.1601-1848.2003.00049.x · Cited by 133
An Investigation of Monoamine Receptors Involved in Antinociceptive Effects of Antidepressants
Yokogawa, F., Kiuchi, Y., Ishikawa, Y., Otsuka, N., Masuda, Y., Oguchi, K., & Hosoyamada, A. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200207000-00029 · Cited by 133
Maes, M. H. J., Libbrecht, I., Hunsel, F. V., Campens, D., & Meltzer, H. Y. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00014 · Cited by 133
Bagdy, G. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00112-x · Cited by 133
Wallace, T. L., Stellitano, K. E., Neve, R. L., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.010 · Cited by 133
The effects of trazodone on sleep in patients treated with stimulant antidepressants
Kaynak, H., Kaynak, D., Gözükırmızı, E., & Guilleminault, C. (2003) · Sleep Medicine · doi:10.1016/j.sleep.2003.06.006 · Cited by 133
Karasawa, J.-I., Shimazaki, T., Kawashima, N., & Chaki, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.032 · Cited by 133
Firbank, M., Harrison, R. M., & O'Brien, J. T. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064927 · Cited by 133
Lei, S., & McBain, C. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.034017 · Cited by 133
Samaha, A., Mallet, N. P., Ferguson, S. M., Gonon, F., & Robinson, T. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1205-04.2004 · Cited by 133
Prediction of pharmacokinetic properties using experimental approaches during early drug discovery
Chaturvedi, P. R., Decker, C. J., & Odinecs, A. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00228-3 · Cited by 133
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132
The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
Foreman, M. M., Hall, J. L., & Love, R. L. (1989) · Life Science · doi:10.1016/0024-3205(89)90128-8 · Cited by 132
RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders
Iwamoto, K., & Kato, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00608-6 · Cited by 132
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450
Chaki, S., Nakazato, A., Kennis, L. E. J., Nakamura, M., Mackie, C. E., Sugiura, M., Vinken, P., ASHTON, D. S., Langlois, X., & Steckler, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.032 · Cited by 132
Escribá, P. V., Ozaita, A., & García-Sevilla, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300459 · Cited by 132
Stress, Metaplasticity, and Antidepressants
Garcia, R. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362023 · Cited by 132
Masaki, T., Yoshimatsu, H., Chiba, S., Watanabe, T., & Sakata, T. (2001) · Diabetes · doi:10.2337/diabetes.50.2.376 · Cited by 132
Chaki, S., Funakoshi, T., Hirota-Okuno, S., Nishiguchi, M., Shimazaki, T., Iijima, M., Grottick, A. J., Kanuma, K., Omodera, K., Sekiguchi, Y., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081711 · Cited by 132
GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent
Slattery, D. A., Desrayaud, S., & Cryan, J. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073536 · Cited by 132
Steiger, A., & Holsboer, F. (1997) · SLEEP · doi:10.1093/sleep/20.11.1038 · Cited by 131
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
Lähdesmäki, J., Sallinen, J., MacDonald, E., Kobilka, B. K., Fagerholm, V., & Scheinin, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00185-9 · Cited by 131
Dickenson, A. H., & Besson, J. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60777-6 · Cited by 131
Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain
Fattaccini, C., Bolaños, F. J., GOZLAN, H., & Hamon, M. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90076-4 · Cited by 131
D, M. F. M., Alpert, J. E., Nierenberg, A. A., Lagomasino, I. T., Sonawalla, S. B., Tedlow, J. R., Worthington, J. J., Baer, L., & Rosenbaum, J. F. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00008 · Cited by 131
Muscarinic Receptors as a Target for Drugs Treating Schizophrenia
Bymaster, F. P., Felder, C. C., Ahmed, S., & McKinzie, D. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007024606249 · Cited by 131
Working memory dysfunction in major depression: an event-related potential study
Pelosi, L., Slade, T., Blumhardt, L. D., & Sharma, V. K. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00354-0 · Cited by 131
The SSRI discontinuation syndrome
Haddad, P. M. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 131
Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.
Stoll, A. L., Pillay, S. S., Diamond, L., Workum, S. B., & Cole, J. O. (1996) · PubMed · Cited by 130
Hirani, K., Khisti, R. T., & Chopde, C. T. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00330-1 · Cited by 130
Brandt, J., Schrauth, S., Veith, A.-M., Froschauer, A., Haneke, T., Schultheis, C., Gessler, M., Leimeister, C., & Volff, J. (2004) · Gene · doi:10.1016/j.gene.2004.11.022 · Cited by 130
Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease
Brück, A., Aalto, S., Nurmi, E., Bergman, J. R., & Rinne, J. O. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.014 · Cited by 130
Amat, J., Tamblyn, J. P., Paul, E. D., Bland, S. T., Amat, P., Foster, A. C., Watkins, L. R., & Maier, S. F. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.052 · Cited by 130
Simonsen, U., García‐Sacristán, A., & Prieto, D. (2002) · Journal of Vascular Research · doi:10.1159/000065541 · Cited by 130
Romanelli, M. N., & Gualtieri, F. (2003) · Medicinal Research Reviews · doi:10.1002/med.10037 · Cited by 130
Martinez, D., Hwang, D., Mawlawi, O., Slifstein, M., Kent, J., Simpson, N., Parsey, R. V., Hashimoto, T., Huang, Y., Shinn, A., et al. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00187-1 · Cited by 130
Are placebo controls necessary to test new antidepressants and anxiolytics?
Khan, A., Khan, S., & Brown, W. A. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002912 · Cited by 130
Wilde, M. I., & Benfield, P. (1995) · Drugs · doi:10.2165/00003495-199549030-00007 · Cited by 129
Serotonin and noradrenaline reuptake inhibitors in animal models of pain
Mochizucki, D. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.620 · Cited by 129
The ligand paradox between affinity and efficacy: can you be there and not make a difference?
Kenakin, T., & Onaran, H. O. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02036-9 · Cited by 129
An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study
Maćkowiak, M., O’Neill, M. J., Hicks, C. A., Bleakman, D., & Skolnick, P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00066-7 · Cited by 129
Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)
Armstrong, S. M., McNulty, O. M., Lemaître, B. J., & Redman, J. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90315-k · Cited by 129
Mechanisms of inverse agonism at G-protein-coupled receptors
Strange, P. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01993-4 · Cited by 129
Complex genomic rearrangements lead to novel primate gene function
Ciccarelli, F. D., von Mering, C., Suyama, M., Harrington, E. D., Izaurralde, E., & Bork, P. (2005) · Genome Research · doi:10.1101/gr.3266405 · Cited by 129
Kłodzińska, A., Chojnacka-Wójcik, E., Pałucha-Poniewiera, A., Brański, P., Popik, P., & Pilc, A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00066-0 · Cited by 129
A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy
Moldofsky, H. (2000) · Sleep Medicine · doi:10.1016/s1389-9457(99)00014-3 · Cited by 129
Youdim, M. B. H., Fridkin, M., & Zheng, H. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.023 · Cited by 128
Done, C., & Sharp, T. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90071-x · Cited by 128
Electroconvulsive Seizure Treatment Increases Cell Proliferation in Rat Frontal Cortex
Madsen, T. M., Yeh, D. D., Valentine, G. W., & Duman, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300565 · Cited by 128
Hillegaart, V., & Ahlénius, S. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702239 · Cited by 128
Davies, M. A., Compton-Toth, B. A., Hufeisen, S. J., Meltzer, H. Y., & Roth, B. L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2017-1 · Cited by 128
Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder
Xie, X., & Hagan, R. M. (1998) · Neuropsychobiology · doi:10.1159/000026527 · Cited by 128
Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men
Antonijevic, I. A., Murck, H., Bohlhalter, S., Frieboes, R.-M., Holsboer, F., & Steiger, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00057-5 · Cited by 128
Transthyretin is involved in depression‐like behaviour and exploratory activity
Sousa, J. C., Grandela, C., Fernández‐Ruíz, J., de Miguel, R., de Sousa, L., Magalhães, A., Saraiva, M. J., Sousa, N., & Palha, J. A. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02309.x · Cited by 128
Is abundant A-to-I RNA editing primate-specific?
Eisenberg, E., Nemzer, S., Kinar, Y., Sorek, R., Rechavi, G., & Levanon, E. Y. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.12.005 · Cited by 128
Nelson, J. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00173-0 · Cited by 127
Smith, D. G., Davis, R. J., Rorick‐Kehn, L. M., Morin, M., Witkin, J. M., McKinzie, D. L., Nomikos, G. G., & Gehlert, D. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300913 · Cited by 127
Structural and functional models of depression: from sub‐types to substrates
Malhi, G. S., Parker, G. B., & Greenwood, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00475.x · Cited by 127
Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter
Miller, G. M., Verrico, C. D., Jassen, A. K., Konar, M., Yang, H. S., Panas, H. N., Bahn, M. E., Johnson, R., & Madras, B. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084459 · Cited by 127
Lorrain, D. S., Matuszewich, L., Friedman, R. D., & Hull, E. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09361.1997 · Cited by 126
Price, M. L., Kirby, L. G., Valentino, R. J., & Lucki, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1114-2 · Cited by 126
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia
Suzuki, T., Uchida, H., Tanaka, K. F., Nomura, K., Takano, H., Tanabe, A., Watanabe, K., Yagi, G., & Kashima, H. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703004012 · Cited by 126
Postsynaptic signaling networks: Cellular cogwheels underlying long-term plasticity
Blitzer, R. D., Iyengar, R., & Landau, E. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.031 · Cited by 126
Goodman, W. K., Bose, A., & Wang, Q. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.11.011 · Cited by 126
Oligomerization of Dopamine and Serotonin Receptors
Lee, S. P., Xie, Z., Varghese, G., Nguyen, T., O'Dowd, B. F., & George, S. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00155-x · Cited by 126
Glickstein, S. B., DeSteno, D. A., Hof, P. R., & Schmauss, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh202 · Cited by 126
Freeman, C. P. L., Trimble, M., Deakin, J. F. W., Stokes, T., & Ashford, J. J. (1994) · PubMed · Cited by 125
Guadaño‐Ferraz, A., Benavides‐Piccione, R., Venero, C., Lancha, C., Vennström, B., Sandi, C., DeFelipe, J., & Bernal, J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001196 · Cited by 125
Borsini, F., Evans, K., Jason, K., Rohde, F., Alexander, B., & Pollentier, S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00219.x · Cited by 125
Dopamine D2 Receptors in Signal Transduction and Behavior
Picetti, R., Saiardi, A., Samad, T. A., Bozzi, Y., Baik, J., & Borrelli, E. (1997) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.20 · Cited by 125
Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat
Sara, S. J., & Devauges, V. (1989) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(89)91039-x · Cited by 125
Rada, P. V., Mark, G. P., Pothos, E. N., & Hoebel, B. G. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90145-2 · Cited by 125
Hughes, Z. A., Starr, K. R., Langmead, C. J., Hill, M., Bartoszyk, G. D., Hagan, J. J., Middlemiss, D. N., & Dawson, L. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.018 · Cited by 125
Michelson, D., Bancroft, J., Targum, S. D., Kim, Y., & Tepner, R. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.239 · Cited by 125
Helm, K. A., Haberman, R. P., Dean, S. L., Hoyt, E. C., Melcher, T., Lund, P. K., & Gallagher, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.019 · Cited by 125
Rutten, K., de Vente, J., Şık, A., Ittersum, M. M., Prickaerts, J., & Blokland, A. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.04.021 · Cited by 125
Brocco, M., Dekeyne, A., Veiga, S., Girardon, S., & Millan, M. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00701-8 · Cited by 124
Self-citationXie, Z., Lee, S. P., O’Dowd, B. F., & George, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00918-7 · Cited by 124
Grant, M. M., & Weiss, J. M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00936-7 · Cited by 124
Otte, C., Marmar, C. R., Pipkin, S. S., Moos, R. H., Browner, W. S., & Whooley, M. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.003 · Cited by 124
Combination Spinal Analgesic Chemotherapy: A Systematic Review
Walker, S. M., Goudas, L. C., Cousins, M. J., & Carr, D. B. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200209000-00033 · Cited by 124
Frye, C. A., Walf, A. A., Rhodes, M. E., & Harney, J. P. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.020 · Cited by 124
Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells
Deák, F., Lasztóczi, B., Pacher, P., Petheö, G. L., Kecskeméti, V., & Spät, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00206-3 · Cited by 124
Gal, C. S., Wagnon, J., Tonnerre, B., Roux, R., Garcia, G., Griebel, G., & Aulombard, A. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00035.x · Cited by 124
Sitte, H. H., Farhan, H., & Javitch, J. A. (2004) · Molecular Interventions · doi:10.1124/mi.4.1.38 · Cited by 124
Abdu, T. A. M., Neary, R. H., Elhadd, T. A., Akber, M., & Clayton, R. N. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01320.x · Cited by 124
Millan, M. J., Péglion, J.-L., Lavielle, G., & Monneyron, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)89962-1 · Cited by 124
Self-citationSchmitt, J. A. J., Kruizinga, M. J., & Riedel, W. J. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500304 · Cited by 124
Sallinen, J., Haapalinna, A., MacDonald, E., Viitamaa, T., Lähdesmäki, J., Rybnikova, E. A., Pelto‐Huikko, M., Kobilka, B. K., & Scheinin, M. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000543 · Cited by 124
Carpenter, L. L., Moreno, F. A., Kling, M. A., Anderson, G. M., Regenold, W. T., Labiner, D. M., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.025 · Cited by 123
Alternative diagnostic criteria for major depressive disorder in patients with chronic pain
Wilson, K. G., Mikail, S. F., D’Eon, J. L., & Minns, J. E. (2001) · Pain · doi:10.1016/s0304-3959(00)00440-1 · Cited by 123
Gehlert, D. R., Shekhar, A., Morin, S. M., Hipskind, P. A., Zink, C., Gackenheimer, S. L., Shaw, J., Fitz, S. D., & Sajdyk, T. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.030 · Cited by 123
Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential
Herpfer, I., & Lieb, K. (2005) · CNS Drugs · doi:10.2165/00023210-200519040-00001 · Cited by 123
Fluoxetine efficacy in menopausal women with and without estrogen replacement
Amsterdam, J. D., García‐España, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00203-1 · Cited by 123
Moreau, J., Bös, M., Jenck, F., Martin, J. R., Mortas, P., & Wichmann, J. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00015-6 · Cited by 123
Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats
Simmons, R. M. A., Webster, A. A., Kalra, A., & Iyengar, S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00849-3 · Cited by 123
Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression
Overstreet, D. H., & Griebel, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.035 · Cited by 123
Reversal of sexual exhaustion by serotonergic and noradrenergic agents
Rodríguez–Manzo, G., & Fernández‐Guasti, A. (1994) · Behavioural Brain Research · doi:10.1016/0166-4328(94)90019-1 · Cited by 123
Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery
Hasenöhrl, R. U., Souza‐Silva, M. A. D., Nikolaus, S., Tomaz, C. A. B., Brandão, M. L., Schwarting, R. K. W., & Huston, J. P. (2000) · Neuropeptides · doi:10.1054/npep.2000.0824 · Cited by 123
Jayanthi, L. D., Samuvel, D. J., Blakely, R. D., & Ramamoorthy, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009555 · Cited by 123
Hyperactivity and Reduced Energy Cost of Physical Activity in Serotonin 5-HT2C Receptor Mutant Mice
Nonogaki, K., Abdallah, L., Goulding, E. H., Bonasera, S. J., & Tecott, L. H. (2003) · Diabetes · doi:10.2337/diabetes.52.2.315 · Cited by 123
Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala
Wennström, M., Hellsten, J., & Tingström, A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.011 · Cited by 123
Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122
Yoshimizu, T., & Chaki, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.073 · Cited by 122
Bupropion occupancy of the dopamine transporter is low during clinical treatment
Meyer, J. H., Goulding, V. S., Wilson, A. A., Hussey, D., Christensen, B. K., & Houle, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1166-3 · Cited by 122
New insights into the mechanisms of antidepressant therapy
Schloss, P. D., & Henn, F. A. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.02.001 · Cited by 122
Mirtazapine versus amitriptyline in the long-term treatment of depression
Montgomery, S., Reimitz, P., & Zivkov, M. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00002 · Cited by 122
Moret, C., & Briley, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00581-1 · Cited by 122
Bayer, L., Eggermann, E., Serafin, M., Grivel, J., Machard, D., Mühlethaler, M., & Jones, B. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.032 · Cited by 122
Modafinil increases histamine release in the anterior hypothalamus of rats
Ishizuka, T., Sakamoto, Y., Sakurai, T., & Yamatodani, A. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00006-5 · Cited by 122
The effects of paroxetine and nefazodone on sleep: a placebo controlled trial
Sharpley, A. L., Williamson, D. J., Attenburrow, M. E. J., Pearson, G., Sargent, P., & Cowen, P. J. (1996) · Psychopharmacology · doi:10.1007/bf02246410 · Cited by 122
Mirtazapine Substitution in SSRI-Induced Sexual Dysfunction
Gelenberg, A. J., Laukes, C., McGahuey, C., Okayli, G., Moreno, F., Zentner, L., & Delgado, P. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0506 · Cited by 122
Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine
Heaton, J. P. W. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00023-3 · Cited by 122
The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder
Iosifescu, D. V., Nierenberg, A. A., Alpert, J. E., Smith, M., Bitran, S., Dording, C., & Fava, M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2122 · Cited by 122
Late-onset depression: genetic, vascular and clinical contributions
Hickie, I. B., Scott, E. M., Naismith, S. L., Ward, P. B., Turner, K. A., Parker, G. B., Mitchell, P. B., & Wilhelm, K. A. (2001) · Psychological Medicine · doi:10.1017/s0033291701004731 · Cited by 122
Cassano, G. B., Puca, F., Scapicchio, P. L., Trabucchi, M., & Italian Study Group on Depression in Elderly Patients (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0504 · Cited by 121
Gold, P. W., Gabry, K. E., Yasuda, M. R., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00022-6 · Cited by 121
Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors
Sharpley, A. L., Elliott, J. M., Attenburrow, M.-J., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90077-9 · Cited by 121
Newman‐Tancredi, A., Nicolas, J., Audinot, V., Gavaudan, S., Verrièle, L., Touzard, M., Chaput, C., Richard, N., & Millan, M. J. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005243 · Cited by 121
Self-citationRubín, R. T., Heist, E. K., McGeoy, S. S., Hanada, K., & Lesser, I. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070052008 · Cited by 121
Treatment of obsessive‐compulsive disorder in patients who have comorbid major depression
Abramowitz, J. S. (2004) · Journal of Clinical Psychology · doi:10.1002/jclp.20078 · Cited by 121
GABAB receptor subunit expression in glia
Charles, K. J., Deuchars, J., Davies, C. H., & Pangalos, M. N. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00162-3 · Cited by 121
New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects
Serretti, A., Ronchi, D. D., Lorenzi, C., & Berardi, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456043 · Cited by 121
Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation
Huang, S. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.203 · Cited by 121
Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitation
Salim, K., Fenton, T. R., Bacha, J. I., Urien-Rodriguez, H., Bonnert, T. P., Skynner, H. A., Watts, E., Kerby, J., Heald, A., Beer, M. S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201539200 · Cited by 121
Heterogeneity of schizophrenia: a study of individual neuropsychological profiles
Kremen, W. S., Seidman, L. J., Faraone, S. V., Toomey, R., & Tsuang, M. T. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.022 · Cited by 120
Dopamine agonist monotherapy in Parkinson's disease
Clarke, C. E., & Guttman, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11668-0 · Cited by 120
Lisanby, S. H., & Belmaker, R. H. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:3<178::aid-da10>3.0.co;2-n · Cited by 120
Arias, B., Catalán, R., Gastó, C., Gutiérrez, B., & Fañanás, L. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049037 · Cited by 120
Coull, J. T., Sahakian, B. J., & Hodges, J. R. (1996) · Psychopharmacology · doi:10.1007/bf02246578 · Cited by 120
Costall, B., & Naylor, R. J. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482624 · Cited by 120
Corticosteroid receptors in the brain: gene targeting studies
Kellendonk, C., Gass, P., Kretz, O., Schütz, G., & Tronche, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00638-4 · Cited by 120
Gulinello, M. E., Gong, Q. H., & Smith, S. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00171-5 · Cited by 120
Activation of dopamine D 4 receptors by ABT-724 induces penile erection in rats
Brioni, J. D., Moreland, R. B., Cowart, M., Hsieh, G. C., Stewart, A. O., Hedlund, P., Donnelly‐Roberts, D. L., Nakane, M., Lynch, J. J., Kolasa, T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308292101 · Cited by 120
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.